Therapeutic nuclear medicine  combines tumour targeting with a therapeutic dose of radiation.

Such targeted radiopharmaceutical therapies can be used to treat cancer through the use of cancer-targeting molecules.  These molecules incorporate a therapeutic dose of radiation within their structure.  These cancer-targeting molecules are able to selectively associate with cancer cells, by binding to receptors that are expressed in high amounts on those cells.

This enables precise delivery of radiation to the cancer cells and kills them.

Blue Earth Therapeutics, our sister company to Blue Earth Diagnostics, is exploring promising therapeutic leads for treatment of disease.  Find out more at:


PP-UK-0582 / January 2023